ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Cancer, AIDS Patient Advocates List Drug Development Concerns

May 12, 1989

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986